연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
907. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS, Kim MA, Kim TM, Lee SH, Kim DW, Im SA, Kim TY, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Choe KJ, Kim NK.
Br J Cancer. 2009 Mar 10;100(5):732-8.
Link
906. Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
Yoon YK, Kim HP, Han SW, Hur HS, Oh do Y, Im SA, Bang YJ, Kim TY.
Mol Cancer Ther. 2009 Sep;8(9):2526-36. Epub 2009 Sep 15.
Link
905. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW.
Ann Oncol. 2009 Oct;20(10):1688-96. Epub 2009 Jun 19.
Link
904. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW.
Breast Cancer Res. 2009;11(2):R22. Epub 2009 Apr 28
Link
903. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Cho JA, Lee YS, Kim SH, Ko JK, Kim CW.
Cancer Lett. 2009 Mar 18;275(2):256-65. Epub 2008 Nov 25.
Link
902. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group.
Lee TS, Kim JW, Kim TJ, Cho CH, Ryu SY, Ryu HS, Kim BG, Lee KH, Kim YM, Kang SB; Korean Gynecologic Oncology Group.
Gynecol Oncol. 2009 Oct;115(1):26-31. Epub 2009 Jul 26.
Link
901. Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer.
Kim K, Kim MJ, Chung HH, Choi SC, Ryu SY, Kim JW, Park NH, Song YS, Kang SB.
Med Hypotheses. 2009 Dec;73(6):1005-7. Epub 2009 Jun 23.
Link
900. Clinical impact of under-diagnosis by frozen section examination is minimal in borderline ovarian tumors.
Kim K, Chung HH, Kim JW, Park NH, Song YS, Kang SB.
Eur J Surg Oncol. 2009 Sep;35(9):969-73. Epub 2009 Mar 25.
Link
899. Disease confined within the ovary and smaller amount of ascites are good prognostic factors for survival of patients with squamous cell carcinoma arising from mature cystic teratoma of the ovary: a case series in Korea and review of the published reports.
Kim HS, Kim JW, Chung HH, Park NH, Song YS, Kang SB.
J Obstet Gynaecol Res. 2009 Feb;35(1):99-105.
Link
898. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
Kim HS, Kim MK, Chung HH, Kim JW, Park NH, Song YS, Kang SB.
Gynecol Oncol. 2009 May;113(2):264-9. Epub 2009 Feb 8.
Link